Fuse Medical (FZMD) stock price, revenue, and financials

Fuse Medical market cap is $689.1 k, and annual revenue was $22.90 m in FY 2019

$689.1 K

FZMD Mkt cap, 22-Sept-2020

$4 M

Fuse Medical Revenue Q2, 2020
Fuse Medical Gross profit (Q2, 2020)2.2 M
Fuse Medical Gross profit margin (Q2, 2020), %55.2%
Fuse Medical Net income (Q2, 2020)-423.4 K
Fuse Medical EBIT (Q2, 2020)-398.5 K
Fuse Medical Cash, 30-Jun-20201.2 M
Fuse Medical EV760.2 K

Fuse Medical Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

941.1k1.7m567.6k26.4m26.3m22.9m

Revenue growth, %

504%(66%)

Cost of goods sold

485.4k664.3k204.0k14.6m13.4m11.8m

Gross profit

455.7k1.0m363.6k11.8m13.0m11.1m

Gross profit Margin, %

48%60%64%45%49%49%

General and administrative expense

101.6k109.3k1.5m1.8m854.1k5.4m8.5m8.5m

Operating expense total

101.6k109.3k1.8m1.8m855.6k11.0m14.9m15.5m

Depreciation and amortization

14.5k49.7k107.1k

EBIT

(101.6k)(109.3k)(1.3m)(792.0k)(492.1k)818.0k(2.0m)(4.3m)

EBIT margin, %

(142%)(47%)(87%)3%(7%)(19%)

Interest expense

30.0571.01.2k9.5k129.4k118.4k133.9k

Interest income

30.0

Pre tax profit

3.6m(2.5m)

Income tax expense

40.8k(386.8k)781.1k

Net Income

(101.6k)(109.9k)(1.4m)(801.5k)(585.9k)699.7k4.0m(3.3m)

Quarterly

USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

161.6k207.1k262.5k487.3k442.9k192.9k120.6k107.6k148.2k334.7k428.2k6.0m5.7m6.8m4.8m5.1m5.7m4.6m4.0m

Cost of goods sold

58.8k72.7k93.4k178.3k165.3k81.3k20.8k42.5k48.3k115.0k169.8k3.1m3.8m3.0m2.0m2.2m4.8m2.0m1.8m

Gross profit

102.7k134.4k169.1k309.1k277.6k111.7k99.8k65.0k99.8k219.7k258.4k2.9m1.9m3.7m2.8m2.9m928.4k2.7m2.2m

Gross profit Margin, %

64%65%64%63%63%58%83%60%67%66%60%48%34%55%59%56%16%57%55%

General and administrative expense

22.2k23.9k32.2k24.4k22.2k48.1k18.4k218.9k529.5k384.7k425.0k755.4k232.2k186.5k182.1k250.7k219.3k216.9k2.2m2.3m1.9m2.4m2.0m2.3m2.5m1.2m

Operating expense total

22.2k23.9k32.2k24.4k22.2k48.1k18.4k218.9k580.4k384.7k425.0k755.4k232.2k186.5k182.1k252.9k220.3k220.3k3.8m3.9m3.3m3.4m3.0m4.0m3.9m2.6m

Depreciation and amortization

1.9k996.0384.02.1k3.7k4.8k25.7k25.6k25.6k30.0k30.8k

EBIT

(22.2k)(23.9k)(32.2k)(24.4k)(22.2k)(48.1k)(18.4k)(116.2k)(446.0k)(215.5k)(115.9k)(477.8k)(120.6k)(86.7k)(117.1k)(153.1k)(602.0)38.1k(907.5k)(2.0m)394.1k(600.1k)(154.5k)(3.1m)(1.2m)(398.5k)

EBIT margin, %

(72%)(215%)(82%)(24%)(108%)(62%)(72%)(109%)(103%)0%9%(15%)(34%)6%(13%)(3%)(54%)(27%)(10%)

Interest expense

10.05.098.0228.0335.0777.09.7k27.4k1.6k1.9k2.9k3.3k1.8k31.8k35.9k40.0k25.9k25.4k28.0k34.9k31.0k24.0k

Interest income

10.05.0

Pre tax profit

(943.4k)(2.0m)368.2k(625.5k)(182.5k)(3.1m)(1.3m)(422.5k)

Income tax expense

(208.4k)(388.3k)91.0k(114.5k)(40.4k)926.5k4.7k946.0

Net Income

(22.2k)(23.9k)(32.2k)(24.5k)(22.4k)(48.4k)(19.2k)(125.9k)(473.4k)(217.1k)(117.8k)(480.6k)(123.9k)(88.4k)(113.4k)(116.4k)(7.3k)31.3k(735.0k)(1.6m)277.2k(511.0k)(142.1k)(4.1m)(1.3m)(423.4k)

Fuse Medical Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

334.0801.067.6k8.2k667.5k804.7k844.3k1.1m

Accounts Receivable

196.2k298.0k6.6m5.2m6.2m

Prepaid Expenses

5.2k10.7k49.3k18.8k32.5k29.6k39.9k

Inventories

131.4k81.2k25.3k10.6m11.1m7.9m

Current Assets

5.5k11.5k494.4k406.2k754.4k18.0m17.2m15.2m

PP&E

49.0k25.0k8.9k16.9k43.0k32.6k

Goodwill

820.7k2.9m2.0m

Total Assets

5.5k11.5k545.9k435.0k767.1k19.2m22.2m18.4m

Accounts Payable

49.7k33.1k276.6k295.6k83.4k2.6m2.7m2.8m

Short-term debt

3.4m1.5m1.9m

Current Liabilities

49.7k33.1k347.4k330.0k316.5k8.0m7.1m8.0m

Long-term debt

17.3k100.0k

Total Debt

34.5k100.0k3.4m1.5m1.9m

Total Liabilities

50.3k347.4k430.0k316.5k27.2m20.7m19.6m

Common Stock

35.7k58.5k55.1k68.9k671.6k714.9k731.2k

Additional Paid-in Capital

3.2m3.3m1.7m2.3m3.2m(8.7m)642.4k

Retained Earnings

(3.3m)(3.4m)(1.5m)(2.3m)(2.9m)751.8k(2.6m)

Total Equity

(44.2k)(38.8k)198.5k5.0k450.6k(8.0m)1.5m(1.2m)

Debt to Equity Ratio

-0.9 x-0.4 x

Debt to Assets Ratio

3 x0.2 x

Financial Leverage

-0.1 x-0.3 x2.7 x87.8 x1.7 x-2.4 x15.1 x-15 x

Quarterly

USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

22.3k6.2k244.0154.0162.02.0k6.6k658.7k522.6k58.3k17.1k57.2k85.4k120.8k61.7k445.5k445.3k472.2k797.8k690.0k594.9k851.8k841.8k1.0m753.3k1.2m

Accounts Receivable

110.1k110.5k191.8k315.6k173.3k84.1k34.8k22.3k122.7k216.2k285.5k4.7m3.6m3.5m3.2m3.9m4.8m4.4m3.0m

Prepaid Expenses

6.9k9.4k3.3k1.4k806.026.8k18.7k5.6k24.7k30.1k56.0k43.2k19.1k9.6k5.2k29.3k29.3k24.7k30.8k36.4k22.1k32.2k18.5k17.4k117.4k87.8k

Inventories

306.8k273.1k151.0k97.1k67.6k46.9k25.5k31.6k21.6k18.8k8.5k10.3m11.2m11.0m11.0m10.8m8.2m7.8m7.1m

Current Assets

29.2k15.6k3.6k1.6k968.028.7k25.2k1.2m930.8k474.5k485.7k341.3k235.6k190.7k120.9k619.1k709.7k790.9k15.8m15.5m15.2m15.1m15.5m14.0m13.1m11.3m

PP&E

45.7k51.6k44.3k36.2k23.5k19.5k15.9k12.4k6.5k5.5k2.0k14.8k35.3k42.2k37.6k32.4k27.1k43.8k33.4k

Goodwill

820.7k820.7k2.9m2.9m2.9m2.9m2.0m2.0m

Total Assets

29.2k15.6k3.6k1.6k968.028.7k25.2k1.2m984.8k521.2k524.4k368.6k258.9k210.4k137.1k629.4k719.0k796.8k17.2m17.4m20.1m20.2m20.7m18.2m16.3m16.3m

Accounts Payable

23.1k33.4k79.9k87.2k103.1k35.7k19.4k196.6k272.2k191.5k311.6k199.9k241.4k205.7k114.0k74.6k89.2k61.8k1.5m2.6m2.4m1.5m2.4m2.5m2.6m2.2m

Short-term debt

(63.0k)95.0k160.0k100.0k2.7m2.0m763.6k1.4m1.3m1.8m1.7m1.2m

Current Liabilities

23.1k33.4k79.9k87.2k103.1k98.7k114.4k360.4k492.1k259.8k370.8k277.7k377.5k417.2k383.3k294.7k391.9k417.5k6.5m6.9m5.9m5.4m5.8m7.3m7.0m6.9m

Long-term debt

15.3k21.1k247.8k727.8k100.0k100.0k100.0k

Total Debt

15.3k21.1k(45.7k)112.3k495.6k745.0k100.0k17.3k100.0k2.7m2.0m763.6k1.4m1.3m1.8m1.7m1.2m

Total Liabilities

102.4k124.2k116.0k131.6k1.3m2.0m359.8k470.8k377.7k377.8k417.8k384.1k295.2k392.1k417.5k25.8m26.2m25.1m19.0m19.3m20.9m18.6m18.9m

Common Stock

35.7k35.7k35.7k35.7k35.7k58.5k58.5k36.0k40.0k58.7k58.9k68.9k68.9k68.9k68.9k158.9k158.9k162.2k671.6k671.6k713.7k714.9k714.9k714.9k731.2k731.2k

Additional Paid-in Capital

3.2m3.2m3.2m3.2m3.2m3.3m3.3m79.6k102.1k1.8m1.8m2.3m2.3m2.3m2.3m3.2m3.2m3.2m(8.5m)(7.1m)(3.6m)244.4k499.1k487.5k805.1k969.5k

Retained Earnings

(3.2m)(3.2m)(3.3m)(3.3m)(3.3m)(3.4m)(3.4m)(147.8k)(1.2m)(1.7m)(1.8m)(2.3m)(2.4m)(2.5m)(2.6m)(3.0m)(3.0m)(3.0m)(735.0k)(2.4m)(2.1m)240.8k98.6k(4.0m)(3.9m)(4.3m)

Total Equity

6.1k(17.8k)(76.4k)(100.8k)(123.2k)(87.3k)(106.4k)(32.7k)(1.0m)161.4k53.6k(9.0k)(118.9k)(207.3k)(247.0k)334.2k326.9k379.3k(8.6m)(8.8m)(5.0m)1.2m1.3m(2.8m)(2.3m)(2.6m)

Debt to Equity Ratio

0.5 x-1.1 x-15.1 x-0.7 x0.3 x1.2 x-0.5 x

Debt to Assets Ratio

-1.6 x4.5 x0.4 x0.8 x0 x0.1 x0.1 x

Financial Leverage

4.8 x-0.9 x0 x0 x0 x-0.3 x-0.2 x-37.5 x-1 x3.2 x9.8 x-40.8 x-2.2 x-1 x-0.6 x1.9 x2.2 x2.1 x-2 x-2 x-4 x16.8 x15.7 x-6.6 x-7 x-6.3 x

Fuse Medical Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(101.6k)(109.9k)(1.4m)(801.5k)(585.9k)699.7k4.0m(3.3m)

Depreciation and Amortization

13.3k25.1k14.2k14.5k49.7k107.1k

Accounts Receivable

(54.3k)(116.9k)239.9k(62.1k)917.7k(1.6m)

Inventories

111.7k50.2k55.9k2.0m1.9m1.1m

Accounts Payable

41.8k57.5k93.2k19.0k(128.3k)178.5k(82.8k)39.9k

Cash From Operating Activities

(53.1k)(50.9k)(1.2m)(375.1k)(237.9k)1.6m2.5m(4.7k)

Purchases of PP&E

(61.0k)(8.3k)(20.3k)(41.8k)(15.3k)

Cash From Investing Activities

(70.3k)(7.0k)300.0(11.6k)(104.9k)(15.3k)

Short-term Borrowings

100.0k(17.2k)(15.6m)

Cash From Financing Activities

51.4k1.3m322.8k896.9k(1.6m)(2.3m)275.1k

Net Change in Cash

(53.1k)467.055.2k(59.4k)659.3k26.3k39.6k255.0k

Interest Paid

550.013.4k3.3k6.4k139.5k107.5k94.5k

Quarterly

USDQ2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q1, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(51.3k)(75.2k)(32.2k)(56.6k)(79.1k)(48.4k)(67.6k)(125.9k)(1.1m)(217.1k)(334.9k)(815.5k)(123.9k)(212.3k)(325.7k)(116.4k)(123.7k)(92.5k)(735.0k)(2.4m)(2.1m)(511.0k)(653.1k)(4.7m)(1.3m)(1.7m)

Depreciation and Amortization

2.0k9.5k4.7k13.3k21.9k3.6k7.2k10.7k1.9k2.9k3.2k2.1k5.8k10.7k25.7k51.3k76.9k30.0k60.7k

Accounts Receivable

37.9k29.8k4.4k(123.0k)19.2k213.9k263.2k(275.7k)(64.6k)(158.1k)(227.4k)(2.1m)2.0m2.6m1.8m999.5k(612.8k)1.1m2.1m

Inventories

(63.7k)(30.0k)(19.6k)34.3k63.8k34.3k55.7k(49.6k)3.7k6.5k16.8k373.5k1.5m1.9m76.1k310.0k181.7k(27.3k)1.4m

Accounts Payable

15.2k25.5k30.2k37.5k53.4k2.6k(13.7k)35.5k88.8k(85.1k)35.0k(76.7k)(54.2k)(89.9k)(146.1k)34.5k49.1k21.7k(1.1m)51.5k(440.5k)(1.2m)(318.4k)(186.8k)(181.2k)(513.3k)

Cash From Operating Activities

(31.2k)(47.2k)(90.0)(10.2k)(14.3k)(61.8k)(89.2k)(169.9k)(865.0k)(296.0k)(389.9k)(332.2k)76.9k112.3k(46.7k)(222.3k)(222.5k)(195.5k)734.7k1.7m2.9m88.0k222.5k(88.1k)(76.1k)41.5k

Purchases of PP&E

(46.5k)(59.8k)(525.0)(1.6k)(24.2k)(36.0k)(20.8k)(20.8k)

Cash From Investing Activities

(46.5k)(69.1k)(525.0)(930.0)300.0300.0300.0300.0300.0300.0(24.2k)(99.1k)(20.8k)(20.8k)

Short-term Borrowings

(5.2m)249.2k

Cash From Financing Activities

10.0k14.1k63.0k95.0k862.8k1.4m286.8k340.0k322.8k100.0k(741.6k)(1.8m)(3.0m)(80.6k)(224.9k)275.1k(249.2k)47.3k

Net Change in Cash

(31.2k)(47.2k)(90.0)(180.0)(172.0)1.2k5.8k646.4k510.2k(9.3k)(50.4k)(10.4k)77.2k112.6k53.6k(222.0k)(222.2k)(195.2k)(6.9k)(114.7k)(209.8k)7.4k(2.5k)187.0k(346.0k)68.0k

Interest Paid

140.0280.0563.01.7k141.0280.01.6k1.8k3.5k5.3k29.7k64.2k84.9k20.8k42.4k69.3k21.8k40.0k

Fuse Medical Ratios

USDQ2, 2012

Financial Leverage

4.8 x